Background: Patients with pollen allergies are frequently polysensitized. Pollens contain epitopes that are conserved across multiple species. Objective: We sought to demonstrate that cross-reactive T cells that recognize conserved epitopes show higher levels of expansion than T cells recognizing monospecific epitopes because of more frequent stimulation. Method: RNA was sequenced from 9 pollens, and the reads were assembled de novo into more than 50,000 transcripts. T-cell epitopes from timothy grass (Phleum pratense) were examined for conservation in these transcripts, and this was correlated to their ability to induce T-cell responses. T cells were expanded in vitro with P pratense-derived peptides and tested for crossreactivity to pollen extracts in ELISpot assays. Results: We found that antigenic proteins are more conserved than nonimmunogenic proteins in P pratense pollen. Additionally, P pratense epitopes that were highly conserved across pollens elicited more T-cell responses in donors with grass allergy than less conserved epitopes. Moreover, conservation of a P pratense peptide at the transcriptomic level correlated with the ability of that peptide to trigger T cells that were cross-reactive with other non-P pratense pollen extracts. Conclusion: We found a correlation between conservation of peptides in plant pollens and their T-cell immunogenicity within P pratense, as well as their ability to induce cross-reactive T-cell
Patients with pollen allergies are often polysensitized, as evidenced by positive RAST and/or skin prick test results to multiple pollen allergens. The relatively low frequency of monosensitizations can be explained by the presence of cross-reactive IgE epitopes conserved across multiple pollens, which result in immune reactivity to homologous regions in allergens to which the patient was not originally sensitized. 1 In the context of immunotherapy, the high degree of polysensitization in subjects suggests that a single allergen administered in therapeutic mode could be sufficient to induce tolerance. In fact, several investigators have suggested that immunotherapy with a single grass species, such as Phleum pratense, is sufficient to also treat allergies to other grass pollens caused by observed crossreactivity at the IgE level. 2, 3 On the other hand, it is firmly established that allergen-specific T cells play an important role in allergic inflammation 4 and that induction of antigen-specific regulatory T cells 5 or elimination of allergen-specific T H 2 cells might be a prerequisite for the induction of specific tolerance. 6 Yet evaluation of cross-reactivity at the T-cell level has been less documented.
A recent study using tetramer costaining of 6 different MHC-epitope complexes found limited cross-reactivity of these epitopes with homologs in other Pooidea grasses and concluded that multiple grass pollen species immunotherapy is likely to be more beneficial than single-species immunotherapy. 7 Although that study was limited to epitopes from 2 major allergens (Phl p 1 and 5), we have recently shown that a large fraction of P pratense-specific T cells target epitopes contained in timothy grass T-cell antigens (TGTAs) unrelated to the known P pratense allergens that are also major targets of T-cell responses but were initially identified based on their high IgE reactivity. 8 On the basis of these data, we reasoned that a broader evaluation of T-cell cross-reactivity including more epitopes and also those from TGTAs would be of interest, particularly because clinical studies have shown a good degree of success for single-species immunotherapy 9, 10 contrary to what might be expected based on the data presented in the tetramer costaining study for a selected set of epitopes. To gain a comprehensive picture of conservation between different grass, weed, and tree pollens, we sequenced the 
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IUIS: International Union of Immunological Societies SIT: Specific immunotherapy TGTA: Timothy grass T-cell antigen transcriptome of 9 allergenic pollen species and determined how the conservation between P pratense T-cell epitopes and other pollen transcriptomes related to their immunogenicity and their ability to elicit cross-reactive T-cell immune responses.
METHODS

Patient population
Study participants were recruited, as previously described. 11 We drew from a cohort of 55 patients between the ages of 19 and 62 years, and 28 of our patients were female. We only included participants with timothy grass allergy who had skin reactions with wheals of 5 mm or greater in diameter after skin prick testing or P pratense-specific IgE levels of 0.35 kU/L or greater, as determined by RAST, and had a history of seasonal grass pollen allergy symptoms. We did not control for other allergies, and many patients were polysensitized. We included patient samples collected both in and out of the season. Further details about the age, sex, and allergy status of the patients used in our studies can be found in Table E1 in this article's Online Repository at www.jacionline.org. Patients' PBMCs used in T cell cross-reactivity studies were further prescreened based on their reactivity to P pratense peptides after timothy grass culture.
RNA sequencing and de novo transcriptome assembly
Total RNA of the pollen extract was isolated, as previously described. 12 RNA was sequenced on a HiSeq 2500 Sequencer (Illumina, Sn Diego, Calif). Replicate samples were run across all lanes of the sequencer to generate paired reads of 100 bp in each direction. Before assembly, several preprocessing steps were performed: (1) reads not passing Illumina filters were discarded, (2) portions of reads matching adapter/primer sequences were trimmed, (3) 39 regions of reads following a low-quality score (Q < 20) were discarded, and (4) remaining reads of less than 30 bp in length were discarded. These preprocessing steps were performed with a combination of FASTX-toolkit (0.0.13.2) 13 and cutadapt (1.3).
14 High-quality reads were assembled into transcripts by using Trinity (r2012-10-05), 15 specifying ''-min_kmer_cov 2'' to ensure each sequence was observed at least twice.
In vitro expansion of allergen-specific T cells from PBMCs
PBMCs were isolated from whole blood by means of density gradient centrifugation and cryopreserved, as previously described. 8 For in vitro expansion, cells were thawed and cultured with RPMI 1640 (Omega Scientific, Tarzana, Calif) supplemented with 5% human AB serum (Cellgro, Manassas, Va) at a density of 2 3 10 6 cells/mL in 24-well plates (BD Biosciences, San Jose, Calif) and stimulated with peptide (0.5 mg/mL). Cells were kept at 378C in a 5% CO 2 atmosphere, and additional IL-2 (10 U/mL; eBioscience, San Diego, Calif) was added every 3 days after initial antigenic stimulation. On day 14, cells were harvested and screened for cytokine production by means of ELISpot after restimulation with peptides or pollen extracts.
ELISpot assays
Production of IL-5 from in vitro-expanded PBMCs in response to peptide pool or extract stimulation was measured with an ELISpot, as previously described. 16 Briefly, 1 3 10 5 cells per well were incubated with a peptide pool (5 mg/mL) or extract (50 mg/mL, except for oak, which was tested at 25 mg/mL). After 22 hours, cells were removed, and plates were washed and incubated with 2 mg/mL biotinylated anti-human IL-5 antibody (Mabtech, Cincinnati, Ohio) at 378C. After 2 hours, plates were washed, and avidinperoxidase complex was added (Vector Laboratories, Burlingame, Calif) for 1 hour at room temperature. Peroxidase-conjugated spots were developed with 3-amino-9-ethylcarvazole solution (Sigma-Aldrich, St Louis, Mo).
T-cell clones
PBMCs were labeled with carboxyfluorescein succinimidyl ester and cultured in complete RPMI 1640 supplemented with 2 mmol/L glutamine, 1% (vol/vol) nonessential amino acids, 1% (vol/vol) sodium pyruvate, penicillin (50 U/mL), streptomycin (50 mg/mL), and 5% human serum (Swiss Red Cross, Bern, Switzerland) at a density of 2 3 10 6 cells/mL in 24-well plates. Cells were stimulated with pools of peptides (0.5 mg/mL per peptide), and rIL-2 (10 U/mL) was added on day 3 after initial antigenic stimulation. At day 11, cells were stained with Pacific blue-labeled anti-inducible costimulator mAb (C398.4A; BioLegend, San Diego, Calif) and BV785-labeled anti-CD25 mAb (BC96; BioLegend). carboxyfluorescein succinimidyl ester-low, inducible costimulator-positive, CD25
1 cells were sorted and cloned by means of limiting dilution, as previously described.
17
T-cell clones were screened at day 20 after initial stimulation by culturing 3 3 10 4 T cells/well with autologous irradiated (95 Gy) EBVtransformed B cells (2 3 10 4 ) in the absence or presence of allergen extracts (50 mg/mL) or peptides (0.5 mg/mL). Mycobacterium tubercolosis lysate (5 mg/mL) was used as a negative control. Proliferation was measured on day 3 after a 16-hour pulse with tritiated thymidine (GE Healthcare, Fairfield, Conn).
RESULTS
Determining sequence conservation among a diverse selection of pollen species
To address the potential effect of sequence conservation and T-cell cross-reactivity on allergic responses, we selected 9 pollen species that represent the 3 major groups of pollen allergens (grasses, weeds, and trees Because no pollen transcriptomic data were available for any of these, we isolated and sequenced pollen RNA and assembled the reads de novo into transcripts, resulting in more than 50,000 transcripts for each pollen. Table E2 in this article's Online Repository at www.jacionline.org provides an overview of the read counts and assembly statistics.
As a quality control, for each pollen transcriptome, we examined whether the known IgE-reactive allergens listed by the International Union of Immunological Societies (IUIS) were reidentified in our analysis. A total of 26 allergens are listed by IUIS (minimum length, 50 residues), covering all pollen species we sequenced (except for sweet vernal grass). For 23 of these allergens, we identified transcripts that had more than 90% sequence identity for more than 50% of the length of previously described allergens (Table I) . For 2 of the 3 remaining allergens (Poa p 5 and Que a 1), isoforms of the IUIS allergens that met these criteria were listed in Allergome. 18 Thus our transcriptomic analysis reidentified isoforms of all but 1 (Amb p 5) of the known allergens from the pollen species we sequenced.
Next, we wanted to determine the degree of conservation of the 10 IgE-reactive P pratense allergens listed by the IUIS. We assessed the conservation of 15-mer peptides within each protein because this constitutes the typical length of an MHC class II-restricted T-cell epitope. Peptides were considered conserved if a transcript encoding a homolog with 2 or fewer residue mismatches was found. Fig 1, A, plots the percentage of peptides conserved in all the grasses we sequenced (pangrass) or even in all pollens (panpollen) for each of the IUIS allergens. A broad spectrum of conservation was detected. Less than 20% of the Phl p 2-, 4-, 5-, and 6-derived peptides were conserved across grasses. By contrast, Phl p 7, 11, and 12 peptides were highly homologous, with more than 60% of the peptides conserved across all grasses. Phl p 1, 3, and 13 exhibited intermediate conservation, with 30%, 34%, and 58% of their peptides conserved in pangrasses, respectively. A similarly broad range of conservation was observed for panpollens, with Phl p 11 and 12 showing greater than 60% conservation.
Sequence conservation contributes to immunogenicity
To test the hypothesis that the level of conservation of a protein across pollens can contribute to its immunogenicity, we examined proteins distinct from IUIS allergens that were recently identified in a transcriptomic and proteomic characterization of P pratense pollen. We assembled 2 sets of proteins. The first set contained 13 TGTAs (ie, all P pratense proteins distinct from the IUIS allergens for which we have detected T-cell responses in > _20% of allergic patients in our original screen). 8 The second set of proteins consisted of 14 unreactive proteins identified in the same transcriptomic and proteomic analysis as the TGTAs but for which no T-cell or antibody responses were detected in any allergic donor. Fig E1 in this article's Online Repository at www.jacionline.org shows a breakdown of conservation for each of the proteins in the unreactive protein and TGTA protein sets analogous to Fig 1, A. These data were further condensed in Fig 1, B and C, which compare the pangrass and panpollen conservation of these protein sets to the IUIS IgE allergens. In both the pangrass and panpollen comparisons, the unreactive proteins showed the lowest degree of conservation. The median pangrass conservation of peptides from unreactive proteins was 11% compared with 32% for the IUIS allergens and 65% for the TGTAs. For the panpollen conservation, the medians were 0%, 23%, and 29% for unreactive proteins, IUIS allergens, and TGTAs, respectively. These differences were significant (P < .05, 1-tailed Mann-Whitney test) for both comparisons of unreactive proteins versus TGTAs and for the panpollen conservation comparison of unreactive proteins versus IUIS allergens. The pangrass conservation comparison of unreactive proteins versus IUIS allergens showed the same trend but was less than the significance threshold (P 5 .087).
In conclusion, the data presented in Fig 1 demonstrate that pollen proteins recognized by immune cells of allergic donors, either at the T-cell or IgE level, are more conserved compared with other pollen proteins and that this trend is more pronounced for T-cell allergens. This suggests that sequence conservation might be of particular relevance in the context of T-cell immunogenicity.
To determine whether conservation of the individual peptides correlates with the immunogenicity of a peptide, we studied previously generated IL-5 responses in donors with P pratense allergy. Originally, we tested 648 overlapping peptides from IUIS P pratense allergens 16 in 25 allergic donors. For 85 donor-peptide pairs (patients used are designated IUIS in Table E1 ), a significant IL-5 response was detected. Thus the likelihood of an individual peptide to be immunogenic in an individual donor was as follows:
85/(25 * 648) 5 0.5%.
In our follow-up study testing additional P pratense proteins based on transcriptomic and proteomic analysis, we screened 822 peptides for immune recognition in 20 donors (referred to as TGTA in Table E1 ) and identified 375 donor-peptide hits, 8 corresponding to a 2.3% likelihood for an individual peptide to be immunogenic in an individual donor. Given that the peptides in the second study were preselected based on predicted HLA-binding affinities, a higher hit rate was expected.
Next, we separated peptides into different sets based on the number of pollens in which they were conserved. For each set, we calculated the average frequency with which an individual peptide was immunogenic in an individual donor and normalized these values to an average of 1.0 within each study to make them comparable (Fig 2) . Indeed, peptides from both the IUIS allergens and the TGTAs were more frequently immunogenic if they were more conserved. Peptides that were found to be conserved in only 1, 2, or 3 pollens were 49% less likely to be immunogenic than average, whereas peptides conserved in 8, 9, or 10 pollens were 47% more likely to be immunogenic than average. This correlation is highly significant (r 2 5 0.796, P 5 .00056). Thus conservation of a P pratense peptide across multiple pollens is correlated with an increased likelihood of the peptide being recognized by T cells in subjects with P pratense allergy.
Sequence conservation predicts allergic T-cell responses
We hypothesized that the more frequent recognition of conserved peptides might be a result of selective expansion of cross-reactive T cells by repeated stimulation with various allergen sources. Cross-reactive T cells that recognize epitopes 
All allergens from the 9 pollen species we sequenced for which there was a greater than 50-amino-acid residue protein sequence available from IUIS are listed. The ''Match in transcriptome'' column is set to yes if there was a match with greater than 90% sequence identity over more than 50% of the protein sequence. No sequences of sufficient length were available in IUIS for sweet vernal grass (Anthoxanthum odoratum).
J ALLERGY CLIN IMMUNOL VOLUME 138, NUMBER 2 contained in multiple pollens might be stimulated more frequently than those recognizing epitopes exclusively found in a single source, which could result in dominance of the allergic response to conserved epitopes. To test this hypothesis, we expanded PBMCs from 19 P pratense-reactive donors with individual epitopes derived from TGTA or IUIS allergens (these patients are designated as CR in Table E1 , and the sequence of the peptides used is described in Table E3 in this article's Online Repository at www.jacionline.org). After 14 days, IL-5 and IFN-g release was measured to the epitope itself, P pratense extract, and extracts from other pollen. T cells from subjects with P pratense allergy released much more IL-5 than IFN-g (see Fig E2 in this article's Online Repository at www.jacionline.org). Responses to extracts and peptide pools were expressed as the relative fraction epitope response to account for variation between patients (Fig 3, A) . When we correlated cross-reactive responses to different extracts with transcriptomic conservation of the epitope in those extracts, a clear hierarchy was observed. Non-P pratense extracts in which the P pratense epitope is completely conserved (0 mismatches) showed the highest response, followed by non-P pratense extracts with 1 to 2 mismatches, and the lowest responses were observed for non-P pratense extracts with 3 or more mismatches. The exact same hierarchy was observed when analyzing peptides from IUIS allergens and TGTA peptides separately (see Fig E3 in this article's Online Repository at www.jacionline.org). Thus P pratense epitopes found to be conserved in other pollen transcriptomes were indeed more likely to induce T-cell responses that could cross-recognize different pollen species.
To examine how our results with polyclonal T-cell cultures were reflected on a single-cell level, we generated T-cell clones from PBMCs of patients with P pratense allergy (see the Methods section). Clones were in vitro expanded with the respective peptide used for T-cell clone generation (Fig 3) and then restimulated with the relevant peptide, an irrelevant control peptide, and extracts, as previously described. 17 In Fig 4, A, we show the mean spot-forming cells/million for the polyclonal T-cell line generated by culturing PBMCs with peptide P5. In  Fig 4, B-E, we show clones generated by using the same peptide with the same patients' PBMCs. Additional clones with another peptide (P7) are shown in Fig E4 in this article' s Online Repository at www.jacionline.org. Several of the T-cell clones generated were cross-reactive (Fig 4, B and C) but with different cross-reactivity patterns. We also found some monospecific T-cell clones that reacted only with P pratense or only with birch pollen (Fig 4, D) . The overall cross-reactivity pattern of clones for peptides P5 and P7 are summarized in Table II and compared with T-cell culture cross-reactivity. We find that the diverse specificity of the clones, when averaged, starts to mimic the reactivity pattern of the T-cell culture, with all strongly crossreactive extracts (>30% in the T-cell culture) being represented with cross-reactivity also at the clonal level. These data suggest that the cross-reactivity pattern observed at the polyclonal level (Fig 1, B) and panpollen (Fig 1, C ) conservation of IUIS allergens was then compared with that of proteins identified in P pratense pollen based on a transcriptomic and proteomic analysis. Medians and quantile ranges are indicated by boxes and error bars. P pratense pollen proteins that were not recognized by either T-cell or B-cell responses were less conserved than both IUIS allergens and TGTAs. Asterisks indicate statistically significant differences: P < .05, 1-tailed Mann-Whitney test.
= is the result of a heterogeneous population of clones with varying cross-reactivity patterns.
DISCUSSION
The present study has generated the largest panel of pollen transcriptomes to date to perform an unbiased analysis of the effect of sequence conservation on shaping allergen-specific T-cell responses. We show that within and beyond the dominant IgE allergens, there is a substantial fraction of peptides and antigens that are highly conserved across pollens and that this conservation is positively correlated with their likelihood to elicit an immune response. Notably, we could predict the likelihood of P pratense peptides to induce a cross-reactive T-cell immune response to other pollens based on their degree of sequence conservation in other pollens.
On the basis of these observations, we hypothesize that crossreactions at the level of T-cell responses might play a key role in polysensitization to different allergens. Specifically, as outlined in the model presented in Fig 5, we hypothesize that cross-reactive T cells elicited by allergen exposure will (1) be boosted and selectively expanded by exposure to additional allergens containing the conserved epitope and (2) generate help for any B cell specific for an allergen cross-reactive at the T-cell level through a classic antigen bridge-linked T-cell/B-cell help mechanism, regardless of whether the IgE response is cross-reactive.
The specific pattern of the cross-reactive responses and our data in T-cell clones suggest that this is an MHC/T-cell-dependent response and not a bystander effect. Benjaponpitak et al 19 observed a general increase in IL-4 cytokine production in response to a control allergen and tetanus toxoid during the escalation phase of an immunotherapy regimen. They describe this increase as evidence for a T H 2 bystander effect. If the effects in our culture were similarly nonspecific, we would have observed an increased cytokine release to all extracts tested in our culture and tested to the negative control pool. Instead, we observed a pattern that shows a preferential increase in response to extracts that contain conserved sequences. Additionally, our T-cell clone data show that cells derived from one clone can produce cytokines when stimulated with several extracts pointing more toward true cross-reactivity rather than a bystander effect. However, we observed some low-level cross-reactivity against C dactylon and F excelsior in the T-cell cultures with peptide 7 that were not recapitulated on the clonal level. Therefore we cannot completely exclude that some of the reactivity we observed in our culture system was due to bystander activation.
Allergic cross-reactive responses are relevant in a variety of clinical settings extending beyond pollen and grass allergies. Patients sensitized to shrimp, for example, are very likely to also have positive skin prick test responses to other crustaceans and even other bivalves. 20 Patients with oral allergy syndrome become sensitized to pollen proteins through inhalation and then experience an IgE-mediated allergic reaction against food antigens that are similar in structure. 21 Cross-reactivity of IgE antibodies is determined by means of structural homology of the epitope, 22 and the presence of cross-reactive IgE antibodies is typically reflective of clinical cross-sensitization. 23 The results
FIG 2.
Peptide conservation correlates with immunogenicity. Panels of peptides from timothy grass proteins were previously tested for the ability to induce IL-5 responses in PBMCs from allergic patients after in vitro culture with timothy grass extract in 2 separate cohorts. Peptides from each study were separated into sets based on the number of pollen species in which they were conserved (x-axis). For each set, the average frequency of T-cell responses was calculated and normalized to 1.0 for each study (y-axis). Data for peptides derived from IUIS allergens are shown as blue diamonds, whereas peptides derived from TGTA antigens are shown as red boxes, and averages of the 2 are shown as black circles. The line depicts a linear correlation for the averaged data, which is highly significant with an r 2 value of 0.796. For each peptide, donors with P pratense allergy were selected who reacted to the peptide after expanding PBMCs in vitro with P pratense extract. PBMCs were stimulated with individual peptides for 14 days, and IL-5 responses were measured by using an ELISpot to (1) the peptide itself, (2) P pratense extract, (3) the 9 other extracts for which the transciptomes were sequenced, and (4) peptide pools that did or did not contain the peptide as relevant and irrelevant controls. T-cell cultures that did not induce a robust response of greater than 200 spot-forming cells/million to the peptide itself were excluded (30% of cultures). Reponses to extracts and peptide pools are expressed as the relative fraction of the response to the peptide itself and capped at 100%. Each gray bar represents the average response 6 SEM. Asterisks indicate P values of statistical significance, as indicated on the right according to 1-tailed Mann-Whitney tests.
Relevant peptide pool
of our present study suggest that allergen cross-reactivity at the T-cell level should also be explored in these settings.
In a more general context, the data we present here highlight how the interactions between the immune system and its environment are highly complex and do not fit a simple paradigm in which exposure to a single species of allergen elicits a speciesspecific response. Rather, our data suggest that T-cell responses are shaped by repeated exposure to related species that carry conserved and cross-reactive linear sequences. This phenomenon is not unique to allergies, and in this respect it is noteworthy that a recent study that examined the level of sequence conservation associated with T-cell cross-reactivity in different Dengue viral strains also derived a maximum of 2 substitutions as a threshold beyond which little or no cross-reactivity was observed. 24 Furthermore, we have recently shown that interspecies conservation plays a key role in shaping the repertoire of human T-cell responses to epitopes conserved in different herpes viruses, such as CMV and EBV, 25 and in different species of the Mycobacterium genus. 26 It must be stressed that the observed correlation between the transcriptomic conservation of epitopes and the observed crossreactivity is a statistical phenomenon not deterministically predictive for an isolated sequence. T-cell lines expanded with individual P pratense peptides that are completely conserved in the transcriptomes of other pollens nevertheless sometimes Reactivity from 11 clones for peptide 5 and 3 clones from peptide 7 was averaged and compared with the percentage of cross-reactivity generated by using T-cell culture methods. Irr, Irrelevant control peptide.
show no reactivity to those pollen extracts, whereas other peptides with many substitutions elicit high responses. This is expected because factors other than the peptide sequence itself, notably abundance of the antigen in which it is embedded, can influence reactivity levels. Also, some substitutions are more likely to disrupt cross-reactivity than others, in particular nonconservative substitutions and those that target anchor residues for MHC binding and key residues for T-cell recognition. Although we can show a high polarization toward IL-5-secreting T cells in allergic subjects, we have not shown that cross-reactivity can be observed with other T H 2 cytokines. However, we chose IL-5 because Schulten et al 8 previously showed that it is representative of multiple T H 2 cytokines after extract and peptide pool stimulation.
Additional limitations to our study must be pointed out. First, donor samples were collected both in and out of the allergy season, and the study was not designed or powered to distinguish whether the exposure pattern at the time of sample collection could further affect the reactivity pattern. Future studies will have to test this potential effect of seasonality.
Second, it is possible that some of the cross-reactivity observed is due to bystander activation. Given that the cross-reactivity pattern we observed at the clonal level mimicked that of the polyclonal T-cell cultures, we do not think that bystander activation is a major effect in our system, but its contribution cannot be ruled out.
The fact that there are large numbers of peptides in P pratense that are conserved across pollens and are capable of inducing cross-reactive T-cell responses suggests that there is potential to design cocktails of peptides and antigens that could serve as diagnostic or immunotherapeutic reagents to simultaneously target multiple pollen allergens. It has previously been shown that immunotherapy with P pratense extract can induce crossreactive responses to pollen extracts from other grass species. 2, 3 Our work shows that different T-cell epitopes have different potential for eliciting cross-reactive responses and that this potential is predictable based on sequence conservation of the peptides between different pollens. Thus it should be possible to develop cocktails of peptides that specifically elicit cross-reactive immune responses, which could be used for pangrass or even panpollen immunotherapy. Importantly, it is not necessary that these are the same peptides that elicit T H 2 responses in allergic patients, but it is also conceivable to develop specific immunotherapy (SIT) approaches using conserved peptides present across pollens that elicit bystander suppression of the allergic responses.
In terms of diagnostics, the use of extracts or recombinant allergens that are at least partially conserved across different pollen species means that patients for whom there is a single clinically relevant allergen might still be classified as sensitized to multiple pollens because of cross-reactivity in skin tests or RASTs. 27, 28 FIG 5 . Schematic representation of allergen cross-reactive versus monospecific T-cell epitope recognition. Allergens 1 and 2 contain a conserved T-cell epitope. Therefore cross-reactive T cells that respond to this epitope will be primed more frequently (cross-reactive T-cell in red, top) than T cells that are specific for an epitope unique to a single allergen (allergen monospecific T cell in blue, bottom). Consequently, crossreactive T cells can provide T-cell help to B cells that are specific to different allergens and promote antibody production/isotype switching to IgE. Importantly, both B cells that produce cross-reactive IgE and B cells that produce monospecific IgE can receive help from cross-reactive T cells as long as they process and present a conserved T-cell epitope. APC, Antigen-presenting cells.
It will be worth examining whether the use of T-cell epitopes uniquely conserved in different pollen species could more clearly delineate patient sensitization patterns. This could be useful both to modify and improve the SIT preparations 29 or to instruct patients on what allergens to avoid.
In conclusion, we have assembled a large panel of pollen transcriptomes and used these data to examine the interplay of sequence conservation and T-cell cross-reactivity. Thereby we established thresholds of sequence conservation for T-cell epitopes that have potential immunologic relevance and found that many epitopes exist that are highly conserved across grass, tree, and weed pollens. Our findings have potential relevance for the design of next-generation SIT treatments and development of pollen species-specific allergy diagnostics.
Clinical implications: Our data suggest that conserved epitopes that elicit highly immunogenic T cells could delineate patient sensitization patterns, might inform the design of therapeutics for polysensitized allergic subjects, and refine the understanding of monospecific versus cross-reactive allergic responses. 
FIG E3.
Separate analysis of correlation between cross-reactivity and conservation for IUIS allergen peptides and TGTA peptides. The analysis performed is the same as in Fig 3 but splits out peptides from known IUIS allergens versus TGTA proteins. *P < .05, **P < .01, ***P < .005, and ****P < .001. n.s., Not significant.
FIG E4.
A, Additional T-cell clones generated from the same culture (with P pratense peptide P5) as shown in Fig 4. B, ELISpot data from the cell line (top) and proliferation from individual T-cell clones (bottom) derived from another culture with P pratense peptide P7. SI was calculated by dividing cpm of antigen stimulated wells with cpm of unstimulated wells. Conditions with SI>2 were considered positive (*). 
